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Abstract: A subcutaneous tumor was found in the right abdomen of a 16-week-old male TCRβ and p53 double-knockout 
mouse. The tumor had indistinct borders with the surrounding tissue. The cut surface after formalin fixation was pale 
yellowish white, partially dark red and partly white. Histologically, the tumor was composed of three distinct regions. 
The first region showed pleomorphic cells arranged in sheets. The second region showed spindle cells arranged in inter-
lacing fascicles. The final region contained a mixture of the above mentioned two types of cells. Furthermore, a small 
amount of collagen fibers, round cells, multinucleated giant cells, and cells with eosinophilic granules were observed 
between these tumor cells. Immunohistochemical examination and electron microscopy identified that the pleomorphic 
cells and spindle cells were histiocytes and fibroblasts, respectively, and that the round cells were undifferentiated mes-
enchymal cells. Based on these findings, the tumor was diagnosed as a malignant fibrous histiocytoma. (DOI: 10.1293/
tox.24.255; J Toxicol Pathol 2011; 24: 251–255)
Key words:  malignant fibrous histiocytoma, mouse, TCRβ and p53 double-knockout mouse, spontaneous
A malignant fibrous histiocytoma (MFH) is a tumor 
that is considered to be derived from pluripotential mesen-
chymal stem cells. Histologically, it consists of rich fibrous 
elements and histiocyte-like cells and has various forms. In 
mice, MFH is composed of proliferating spindle cells and 
collagen fibers and classified into a fibrous type with a dis-
tinctive storiform pattern; a myxoid type, which contains 
organic material with abundant acid mucopolysaccharide 
and shows a myxomatous morphology; and a pleomorphic 
type, which mainly consists of proliferating histiocyte-like 
cells and contains many multinucleated giant cells1. There 
are reports on MFH or MFH-like sarcoma in A/J mice, ICR 
mice and genetically modified mice2,3. We report here a case 
of MFH in a 16-week-old male B6.129P2-TcrbTrp53 (T-cell 
receptor β chain and p53 double-knockout; TCR β−/− p53−/−) 
mouse, in which the spontaneous incidence of colon cancer 
is high4,5.
T-cell receptor β chain (TCRβ) is one of the molecules 
that constitute the T-cell receptor, and lack of this molecule 
results in homeostatic defects of the intestinal mucosal im-
mune system. The TCRβ gene-deficient (TCRβ−/−) mouse, 
which has been produced for the purpose of clarifying 
the mechanisms of T-cell genesis and differentiation6–9, is 
known to develop inflammation of the intestinal tract and 
serves as an animal model of inflammatory bowel disease 
that exhibits lesions analogous to those of ulcerative coli-
tis in humans10. The p53 gene is the cause of Li-Fraumeni 
syndrome, which is characterized by hereditary, frequent 
occurrence of diverse malignant neoplasms11, and is also 
an antioncogene (tumor suppressor gene) in which muta-
tions frequently are detected in nonhereditary malignant 
tumors12. The protein encoded by p53 functions to arrest the 
cell cycle in response to DNA damage or to induce apopto-
sis13,14. The p53 gene-deficient (p53−/−) mouse, produced to 
analyze the function of the p53 gene, has been reported to 
exhibit a high incidence of angiosarcoma and spontaneous 
development of malignant lymphomas in various organs15,16.
In the present case, a tumor was found subcutaneously 
in the abdomen of a male TCR β−/− p53−/− mouse. The mouse 
was housed alone in a plastic cage (182 mm × 260 mm × 
128 mm)  in  an  environmentally  controlled  animal  room 
(temperature, 23 ± 3 °C; relative humidity 50 ± 10%; ven-
tilation rate 10–20 times per hour; and a 12-hour light/12-
hour dark cycle) and fed a diet (F-1; Funabashi Farm Co., 
Ltd., Chiba, Japan) and tap water ad libitum. The tumor was 
observed in the right abdomen of this animal at 14 weeks of 
age. A hemorrhage developed on the surface of the tumor 
at 16 weeks of age. The animal was subsequently sacrificed 
due to general health deterioration.
Received: 30 June 2011, Accepted: 28 August 2011  
Mailing address: Minoru Ando, Yakult Central Institute for Microbi-
ological Research, 1796 Yaho, Kunitachi-shi, Tokyo 186-8650, Japan 
TEL: 81-42-577-8960 FAX: 81-42-577-3020  
E-mail: minoru-ando@yakult.co.jp
©2011 The Japanese Society of Toxicologic Pathology
This is an open-access article distributed under the terms of the Cre-
ative Commons Attribution Non-Commercial No Derivatives (by-nc-
nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.MFH in TCR b and p53 Double-knockout Mouse 252
The tumor mass was fixed in 10% phosphate-buffered 
formalin and embedded in paraffin. Paraffin sections were 
stained  with  hematoxylin-eosin,  Masson’s  trichrome  and 
periodic acid Schiff. Immunohistochemical staining with 
anti-vimentin mouse monoclonal antibody (DakoCytoma-
tion, Kyoto, Japan), anti-factor VIII related antigen rabbit 
polyclonal antibody (DakoCytomation), anti-S100a protein 
rabbit  polyclonal  antibody  (DakoCytomation),  anti-F4/80 
rat monoclonal antibody (Abcam, Tokyo, Japan), anti-alpha 
smooth muscle actin rabbit monoclonal antibody (Abcam), 
anti-mouse CD31 rat monoclonal antibody (Abcam), anti-
desmin rabbit polyclonal antibody (Lab Vision, Fremont, 
CA,  USA),  anti-myoglobin  rabbit  monoclonal  antibody 
(Epitomics, Burlingame, CA, USA) and anti-Ki-67 rabbit 
monoclonal  antibody  (Thermo,  Fremont,  CA,  USA)  was 
performed by the streptavidin-biotin complex method.
For  electron  microscopic  examination,  pieces  of  the 
10%  formalin-fixed  tumor  mass  were  first  immersed  in 
phosphate-buffered 2.5% glutaraldehyde and then in phos-
phate-buffered 1% osmium tetroxide for 2 h. After dehy-
dration through a graded ethanol series, the tissue samples 
ware embedded in Epon812 resin. Ultrathin sections were 
prepared and stained with uranyl acetate and lead citrate 
and then observed under a transmission electronmicroscope 
(JEM-1200EX; JEOL, Tokyo, Japan).
At necropsy, a 25 × 25 × 13-mm tumor mass was found 
in the subcutaneous tissue in the right abdomen. Ulceration 
and hemorrhage were observed on the surface of the tumor 
mass, and the tumor margin was not clearly visible macro-
scopically. The cut surface of the formalin-fixed tumor mass 
was yellowish-white, partly dark red and partly white.
Histological examination showed that the tumor occu-
pied the subcutaneous dermis and that there were many foci 
of necrosis and hemorrhages in the tumor mass. In addition, 
ulceration was seen in some parts of the epidermis. The tu-
mor was composed of three distinct regions. The first region 
showed pleomorphic cells arranged in sheets. The second re-
gion showed spindle cells arranged in interlacing fascicles. 
The final region contained a mixture of the above mentioned 
two types of cells. The tumor mass also contained heman-
giopericytoma-like structures (Fig. 1A, B, C), and dissemi-
nated collagen fibers, round cells, multinucleated giant cells 
and other neoplastic cells containing various numbers of cy-
toplasmic eosinophilic granules. The pleomorphic cells had 
an abundant eosinophilic cytoplasm and an atypical nucleus 
with a prominent nucleolus, and some cells showed phago-
cytosis of cellular debris. The spindle cells had an eosino-
philic cytoplasm and an oval nucleus. Masson’s trichrome 
staining showed a small amount of blue-staining collagen 
fibers between the cells. The round cells scattered in the 
tumor contained an eosinophilic cytoplasm and a distinct 
nucleus. These cells showed a high N/C ratio and frequent 
mitoses, and some cells showed PAS-positive eosinophilic 
coarse cytoplasmic granules (Fig. 2A–G).
The pleomorphic cells were immunohistochemically 
positive for vimentin, F4/80 and Ki-67 (Fig. 2B), while they 
were negative for S-100a, desmin, α-SMA, myoglobin, fac-
tor VIII related antigen, and CD31. The spindle cells were 
positive for vimentin and Ki-67 and negative for S-100a, 
F4/80, desmin, α-SMA, myoglobin, factor VIII related anti-
gen, and CD31. The round cells showed similar staining to 
that of the spindle cells, and the multinucleated giant cells 
showed the same staining as the pleomorphic cells. The 
cells with eosinophilic granules were positive for vimentin 
alone and negative to all other antibodies.
Electron microscopy showed that the pleomorphic cells 
had phagosomes and lysosomes containing cellular debris 
(Fig. 3A), a well-developed rough endoplasmic reticulum (r-
ER) and Golgi apparatus in the cytoplasm. Abundant free 
ribosomes and r-ER were observed in the cytoplasm of the 
spindle cells, and the lumen of some r-ERs were expanded. 
These cells had an oval nucleus and a distinct nucleolus and 
the  nuclear  membrane  was  deeply  stained.  Furthermore, 
fibril formation was also seen in the extracellular spaces 
(Fig. 3B). The round cells had a high N/C ratio and con-
tained abundant free ribosomes, a few mitochondria and 
undeveloped r-ERs in the small cytoplasm (Fig. 3C). In the 
cytoplasm of the cells with eosinophilic granules, several 
osmiophilic globules were surrounded by a limiting mem-
brane with a diameter of 1 to 1.5 μm, and some of the osmio-
philic globules contained glycogen granule-like substances 
and granules measuring approximately several hundred nm 
(Fig. 3D).
The tumor mainly consisted of three types of cells, 
including pleomorphic cells, spindle cells and round cells. 
Based on the findings of phagocytosis of cellular debris, pos-
itive immunohistochemical staining for F4/80 and vimentin 
and ultrastructural evidence of phagosomes and lysosomes 
containing cellular debris in the cytoplasm, the pleomorphic 
cells were suggested to be histiocytes. On the other hand, 
the spindle cells demonstrated fasciculation, collagen fibers 
were seen on Masson’s trichrome staining and there was ul-
trastructural evidence of fibril formation. Furthermore, the 
cells were positive for vimentin on immunohistochemical 
staining. The above-mentioned findings suggested that the 
spindle cells might be fibroblasts. It was considered that the 
round cells scattered in the tumor might be undifferentiated 
mesenchymal cells because of their positive reaction to vi-
mentin on immunohistochemical staining and no ultrastruc-
tural evidence of differentiation to other mesenchymal cells. 
Thus, the tumor mass in this case consisted of pleomorphic 
histiocytes, cells undergoing differentiation to fibroblasts 
and undifferentiated mesenchymal cells, and the tumor was 
therefore diagnosed as a MFH.
In this case, some tumor cells contained PAS-positive 
eosinophilic granules that were found to be osmiophilic 
globules surrounded by a limiting membrane with a di-
ameter of 1 to 1.5 μm on electron microscopy. Some of the 
globules contained glycogen granule-like substances and 
granules measuring approximately several hundred nano-
meters. Cells with these features are called eosinophilic 
globule (EG) cells, which were reported in a previous study 
in 18% (27 of 150) of ICR mice with MFH-like sarcoma3. 
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cance of production of EG cells but suggested that EG cells 
are sometimes found in MFH in mice.
The present case did not show proliferation of collagen 
fibers with typical storiform patterns, which is one of the 
distinctive features of MFH, but showed a lot of undifferen-
tiated mesenchymal cells, which suggested that it was a rela-
tively poorly differentiated MFH. The incidence of undif-
ferentiated sarcoma in p53 knockout mice was reported to 
be 14% (8 of 56 mice) by Okada et al., 10% (3 of 30 mice) by 
Harvey et al. and 5% (3 of 60 mice) by Donehower et al.15–17. 
However, there are no reports of undifferentiated sarcoma 
in TCRβ knockout mice. Therefore, the relatively poorly-
differentiated histology of this case might be attributable to 
a p53 gene defect.
This case developed MFH at 16 weeks of age, which 
was a relatively young age. Previous studies reported that 
Fig. 1.  Histopathological findings of the subcutaneous tumor in a T-cell receptor β chain and p53 double-knockout mouse. Lower 
magnification of the tumor. A) Pleomorphic cells arranged in sheets. H-E. B) Spindle cells arranged in interalcing fascicles. 
H-E. C) Hemangiopericytoma-like area.
Fig. 2.  High magnification of the tumor cells. A) Phagocytosis of cell debris by a pleomorphic cell. H-E. B) Pleomorphic cells 
showing positive immunohistochemical staining for F4/80. C) Spindle cells. H-E. D) Scanty collagen fibers by the side of 
spindle cells. M-T. E) Round cells. H-E. F) Eosinophilic globule cells. H-E. G) A multinucleated giant cell. H-E.MFH in TCR b and p53 Double-knockout Mouse 254
the age of onset of spontaneous MFH in nontransgenic mice 
including A/J mice and ICR mice was 1 year old or older2,3. 
Spontaneous MFH has been reported in genetically modi-
fied animals including p53 knockout mice and p53 and trans-
porter for antigen presentation-1 double-knockout mice, but 
the reports did not give the age of onset17,18. The life span of 
p53 knockout mice is approximately 6 months, which sug-
gests that the age of onset of MFH in the above-mentioned 
genetically modified mice may be less than 6 months old. 
In addition, various types of sarcoma including malignant 
lymphoma develop in younger p53 knockout mice under 6 
months old15–18. The above-mentioned findings suggested 
that the relatively younger age of onset, 16 weeks, might be 
attributable to a p53 gene defect.
Many studies have been conducted using various ge-
netically modified mice including p53 gene knockout mice 
to elucidate the mechanism of pathogenesis and to establish 
preventive  methods.  This  case  indicated  that  genetically 
modified mice develop tumors at an early age and that the 
histological  features  are  different  from  those  previously 
reported for nontransgenic mice. Accordingly, this case 
should be taken into consideration when tumors of such ge-
netically modified mice are diagnosed.
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